Almorexant inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets caspase-3, human OX1R, and human OX2R.
Molecular Weight
512.56
Molecular Formula
C29H31F3N2O3
Targets
Caspase-3; human OX1R: 1.3 nM (Kd); human OX2R: 0.17 nM (Kd)
Form
Lyophilized powder
Purity
>98%
Applications
Almorexant can be studied for its effect on regulating wakefulness and sleep.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
